Skip to main content
. Author manuscript; available in PMC: 2022 Mar 4.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2019 Sep 30;20(4):219–225. doi: 10.1016/j.clml.2019.09.601

Figure 1.

Figure 1

Reasons for HU Dose Adjustment or Discontinuation.a-c aAll Dose Changes, Interruptions, and Discontinuations Were Summarized Across All Patients During Their Complete HU Exposure. bCohorts Were Not Mutually Exclusive. cAny Occurrence of Dose Change was Used as the Denominator; the Same Patient Could Contribute to Multiple Dose Adjustments. dInterrupted for ≥ 14 Days

Abbreviation: HU = hydroxyurea.